Clinical trial
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating…
NCT00067015 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00067015 |
|---|---|
| Title | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer |
| Official title | Phase III Randomized Trial Study Comparing the Outcome of High-Dose IMRT (86.4 GY) Alone With IMRT to 75.6 GY Plus Neoadjuvant/Adjuvant Androgen Deprivation in Patients With High Grade Intermediate Risk and Unfavorable Risk Prostate Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | bicalutamide, goserelin acetate, assessment of therapy complications, quality-of-life assessment, radiation therapy |
| Enrollment | 3 |
| Start date | May 1, 2003 |
| Primary completion | Oct 1, 2004 |
| Completion | Sep 1, 2008 |
| First posted | Aug 11, 2003 |
| Last update posted | Dec 22, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: